Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Decaens

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Molecular Cancer Therapeutics|June 2, 2017
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular CarcinomaGaël S Roth, Zuzana Macek Jilkova, Ayca Zeybek Kuyucu, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world settingManon Falette-Puisieux, Jean-Charles Nault, Mohamed Bouattour, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 9, 2015
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRIMarion Roux, Frederic Pigneur, Julien Calderaro, et al.
Cancers|October 13, 2021
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular CarcinomaKeerthi Kurma, Olivier Manches, Florent Chuffart, et al.
Cancers|March 6, 2021
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score AnalysisGaël S Roth, Maxime Benhamou, Yann Teyssier, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 13, 2018
De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic StudyLaurence Renaud, Marie-Noëlle Hilleret, Elsa Thimonier, et al.
Oncotarget|March 16, 2018
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinomaZuzana Macek Jilkova, Ayca Zeybek Kuyucu, Keerthi Kurma, et al.
Abdominal Radiology (New York)|November 8, 2017
Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?Marion Roux, Frederic Pigneur, Laurence Baranes, et al.
Abdominal Radiology (New York)|December 13, 2017
Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?Marion Roux, Frederic Pigneur, Laurence Baranes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2015
Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinomaMuhammad Ramzan, Nathalie Sturm, Thomas Decaens, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Molecular Cancer Therapeutics|June 2, 2017
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular CarcinomaGaël S Roth, Zuzana Macek Jilkova, Ayca Zeybek Kuyucu, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world settingManon Falette-Puisieux, Jean-Charles Nault, Mohamed Bouattour, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 9, 2015
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRIMarion Roux, Frederic Pigneur, Julien Calderaro, et al.
Cancers|October 13, 2021
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular CarcinomaKeerthi Kurma, Olivier Manches, Florent Chuffart, et al.
Cancers|March 6, 2021
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score AnalysisGaël S Roth, Maxime Benhamou, Yann Teyssier, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 13, 2018
De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic StudyLaurence Renaud, Marie-Noëlle Hilleret, Elsa Thimonier, et al.
Oncotarget|March 16, 2018
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinomaZuzana Macek Jilkova, Ayca Zeybek Kuyucu, Keerthi Kurma, et al.
Abdominal Radiology (New York)|November 8, 2017
Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?Marion Roux, Frederic Pigneur, Laurence Baranes, et al.
Abdominal Radiology (New York)|December 13, 2017
Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?Marion Roux, Frederic Pigneur, Laurence Baranes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2015
Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinomaMuhammad Ramzan, Nathalie Sturm, Thomas Decaens, et al.
Pageof 13